Data Integrity challenges in the Lab
|
|
- Regina Juliana May
- 7 years ago
- Views:
Transcription
1 Data Integrity challenges in the Lab Peter Boogaard CEO Industrial Lab Automation 20 April 2016
2 What makes the lab process special? Cost center perception Scientific oriented Lack of standardization Complex technologies Paper based Conservative approach
3 Data Integrity OPTION 1 Loss of intellectual property Potential business impact OPTION 2 Business shutdown Not in accordance with regulations
4 Data integrity refers to maintaining and assuring the accuracy and consistency of data over its entire life-cycle
5 ICHQ10 Pharmaceutical Lifecycle Quality System Research Pharmaceutical Development Technology Transfer Commercial Manufacturing Discontinuation Prior Knowledge GxP Management Responsibilities Process Performance & product Quality Monitoring System Preventive Action / Corrective Action (PACA/CAPA) system Change Management System Management Review 4 PQS elements Enablers Knowledge Management Quality Risk Management
6 Data Integrity is cited in 50% more warning letters in 2013! Falsified batch records Testing into compliance Discarding raw data Source FDA 2013 data
7 US FDA Observations Summary (2013) CFR Part 211 Observations CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS Production & Process Controls (Subpart f) Organisational & Personal (Subpart B) Records & Reports (Subpart J) Equipment (Subpart D) Laboratory Controls (Subpart I) Inadequate investigations of Batch Failures Inadequate raw material testing Deficiencies associated with Lab controls
8 Laboratory data integrity observations Alteration of raw, original data and records Multiple analyses of assay with the same sample without adequate justification Manipulation of a poorly defined analytical procedure and associated data analysis in order to obtain passing results Backdating stability test results to meet the required commitments Creating acceptable test results without performing the test Using test results from previous batches to substitute testing for another batch Source: FDA
9 Data Integrity challenges - Devil is in the Details Laboratory processes may seem similar, but lot of details requires in-depth research to enable consistent and complete findings People Master DATA Common data dictionary Unified specification processes Reporting processes Common workflow processes United naming conventions Validation processes IT integration
10 Single point of truth for (meta) data Fragmented Applications Landscape Source Gartner Inc. /AMR
11 Single point of truth for (meta) data Data integrity Challenges Source Gartner Inc. /AMR
12 Scientific Data Sources
13 DATA INTEGRITY
14 Data Integrity nightmare Spreadsheet COPY/PASTE Madness Project Receive Request Lab LIMS EXCEL Receive UNILAB Lab INSTRUMENT Receive Lab FILE Cut & Paste Cut & Paste Cut & Paste Other tests Receive Lab Excel input ELN WEB Receive Lab EXPORT Other tests Excel input Receive WORDLab Cut & Paste Statistical Receive Lab Analysis Cut & Paste Top Line Receive Lab Creation Receive PDF Lab Receive Customer Lab
15 Simplify And Automate Workflows Learn from other industries Data Integrity Challenges in the Labs- PLA 2016
16 New Alternatives to decrease DI Courtesy of Waters Corp.
17 Self-documenting processes Reducing DI at the source
18 Adopt and use data industry standards & processes Yes, we have enough power for your equipment
19 GMP Regulatory Requirements for Data Integrity Instruments must be qualified and fit for purpose [ (b), ] Software must be validated [ ] Any calculations used must be verified [ (b)] Data generated in an analysis must be backed up [ (b)] Reagents and reference solutions are prepared correctly with appropriate records [ (c)] Methods used must be documented and approved [ (a)] Methods must be verified under actual conditions of use [ (a)(2)] Data generated and transformed must meet the criterion of scientific soundness [ (a)] Test data must be accurate and complete and follow procedures [ (a)] Data and the reportable value must be checked by a second individual to ensure accuracy, completeness and conformance with procedures [ (a)(8)] Derived from the laboratory data integrity definition and the applicable 21 CFR 211 GMP regulations FDA s Focus on lab Data integrity Bob McDowall Part 1
20 Methods to increase integrity in the laboratory Conclusion Implement Risk based processes Define a single point of truth for (meta) data Reduce, automate & simplify workflow complexities Stop spreadsheet madness Implement self-documenting processes at the source Utilize best practice analysis protocols Adopt and use data industry standards & processes Avoid custom software extensions
21 Data Integrity Challenges in the Labs- PLA 2016
22 Data Integrity challenges in the Lab Peter Boogaard CEO Industrial Lab Automation 20 April
23 Laboratory Life Cycle model Meta data capture Analytical data Process data Predicted information Statistical data Laboratory knowledge Regulatory External data consumers
Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence
Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Heather Longden Senior Marketing Manager, Informatics Regulatory Compliance 2015
More informationQUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT
QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT Heather Longden Senior Marketing Manager Waters Corporation Boston Chapter Educational Meeting June 2016 About Waters Lab Informatics Separations
More informationWhite paper: FDA Guidance for Industry Update Process Validation
White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,
More informationFull Compliance Contents
Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex
More informationComputerised Systems. Seeing the Wood from the Trees
Computerised Systems Seeing the Wood from the Trees Scope WHAT IS A COMPUTERISED SYSTEM? WHY DO WE NEED VALIDATED SYSTEMS? WHAT NEEDS VALIDATING? HOW DO WE PERFORM CSV? WHO DOES WHAT? IT S VALIDATED -
More informationUNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)
UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) Nutrition Supplier Meeting, June 30, 2015 Dimitris Catsoulacos Quality Assurance Specialist PRESENTATION OVERVIEW Quality
More informationFDA Guidance for Industry Update - Process Validation
FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead
More informationWhy System Suitability Tests Are Not a Substitute for Analytical Instrument Qualification
White paper System Suitability Tests and AIQ R.D.McDowall PhD Principal, McDowall Consulting Paul Smith European Validation Program Manager, PerkinElmer Nicola Vosloo PhD European Market Development Leader,
More informationData Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International
Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,
More informationWelcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014
Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing
More informationCompliance Control Procedure Execution Management System Reduces Compliance Risks by 10X
Compliance Control Procedure Execution Management System Reduces Compliance Risks by 10X By John Helfrich, VelQuest Corporation INTRODUCTION The top drug GMP violations in 2009 involved failings in manufacturers'
More informationRisk management is one of the new requirements for. An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems
vember 2013 Spectroscopy 28(11) 1 Focus on Quality An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems A risk assessment is presented for determining the amount
More informationComputerised Systems in Analytical Laboratories
ECA Certified Computer Validation Manager Course* New EU Annex 11 and Chapter 4 Requirements will be covered Computerised Systems in Analytical Laboratories Foto: DRK The Electronic Analytical GMP : Integrating
More informationSandoz Private Limited 10/22/15
Sandoz Private Limited 10/22/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Warning Letter VIA UPS WL: 320-16-01 October 22, 2015
More informationINTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to
INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software
More informationCOTS Validation Post FDA & Other Regulations
COTS Validation Post FDA & Other Regulations TABLE OF CONTENTS 1. Abstract 3 2. What is COTS 3 3. Why should COTS require Validation? 3 4. Risk Based Approach 4 5. Validation Approach 6 6. Applicable Regulations
More informationOMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (08) 69 3R Full document title and reference Document type VALIDATION OF COMPUTERISED SYSTEMS Legislative basis - CORE DOCUMENT
More informationElectronic Raw Data and the Use of Electronic Laboratory Notebooks
7th WRIB- M-2 Workshop Electronic Raw Data and the Use of Electronic Laboratory Notebooks Ron Shoup Outline for Today Raw Data- defining it, creating it, and keeping it for posterity Hybrid Data- paper,
More informationMHRA Data Integrity Guidance and Expectations Document
MHRA Data Integrity Guidance and Expectations Document Nichola Stevens Alere International John Andrews Integrity Solutions April 23 rd 2015, Astellas, Chertsey 1 About this Session This is an interactive
More informationValidation and Calibration. Definitions and Terminology
Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an
More informationClinical database/ecrf validation: effective processes and procedures
TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized
More informationPROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION
April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:
More informationICH Q10 - Pharmaceutical Quality System
WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,
More informationWhat is Process Validation?
What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process
More informationReview and Approve Results in Empower Data, Meta Data and Audit Trails
Review and Approve Results in Empower Data, Meta Data and Audit Trails 2013 Waters Corporation 1 What is an audit trail? Systematic story of the data from creation, through interpretation and final assessment
More informationLibrary Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
More informationGxP Process Management Software. White Paper: Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations
GxP Process Management Software : Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations Most FDA violations involve one of the following: Not having procedures in a regulated area
More informationCombination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
More informationAgilent s Kalabie Electronic Lab Notebook (ELN) Product Overview ChemAxon UGM 2008 Agilent Software and Informatics Division Mike Burke
Agilent s Kalabie Electronic Lab Notebook (ELN) Product Overview ChemAxon UGM 2008 Agilent Software and Informatics Division Mike Burke Kalabie: Extending the OpenLAB Architecture Agilent User Interface
More informationFDA Inspection Observations The FDA 483 and Beyond. Objectives
FDA Inspection Observations The FDA 483 and Beyond Presenter: David L. Chesney Vice President and Practice Lead PAREXEL Consulting, Waltham, MA Dave.chesney@parexel.com Objectives Describe history and
More informationGood Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials
Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials Vanessa Grant and Tim Stiles VERSION 2 Published by
More informationAssuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise
Assuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise 2013 Waters Corporation 1 Agenda Electronic Record regulations, Compliance Policy Guides and Warning
More informationQuality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:
NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a
More informationThis interpretation of the revised Annex
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation
More informationElectronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries
White Paper No 01 I December 2010 Implementation of 21 CFR Part 11 in the epmotion Software Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device
More informationValidation Approach and Scope for Business Process System Validation. Epitome Technologies Private Limited
Validation Approach and Scope for Business Validation Epitome Technologies Private Limited PROPOSAL Page 2 of 8 Table Of Contents: 1.0 GENERAL... 3 2.0 SCOPE MODULES COVERED... 3 3.0 QUALIFICATION APPROACH...
More informationCalibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.
Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known
More informationCOMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
More informationGLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
More informationConducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
More informationORACLE PROCESS MANUFACTURING QUALITY MANAGEMENT
ORACLE PROCESS MANUFACTURING QUALITY MANAGEMENT KEY FEATURES Automated stability study management Lot expiration handling and retesting Potency or variability management Quality holds during receiving
More informationHarmonizing Change Control Processes Globally
Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses
More informationTesting Automated Manufacturing Processes
Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls
More informationHow to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters
environmental failure analysis & prevention health technology development How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters Kevin L. Ong, Ph.D., P.E. Managing
More informationPROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
More informationTHE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE
THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE The objective of this article is to discuss the 21 CFR Part 11 compliance utility of the Waters NuGenesis Scientific Data Management System
More informationThomas Schmidt, Wolfgang Lemmerz, and Chris Stumpf Waters Corporation, Milford, MA U.S. INTRODUCTION. QC data and test result management
Increasing Quality Control Testing Efficiency with Compliant-Ready SOP Digital Forms Thomas Schmidt, Wolfgang Lemmerz, and Chris Stumpf Waters Corporation, Milford, MA U.S. INTRODUCTION Pharmaceutical
More informationUNICEF s Quality Assurance System for procurement of medicines
UNICEF s Quality Assurance System for procurement of medicines QA Specialist Peter Svarrer Jakobsen Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers UN City, Copenhagen 23 September
More informationInternational GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories
More informationLaboratory Information Management System
Laboratory Information Management System Lab Inventory Statistical Process Control LIMS Calibration Stability Dispensing Reagents Management Instrument Interfacing ERP Interface Complaint Tracking Process
More informationSiemens Industry Automation Division
Siemens Division Pharmaceutical and Life Science Industries Key Trends in the Pharmaceutical Industry Regulation Economic pressure Risk based approach More patient protection Anti counterfeit E- submission
More informationWorld Health Organization Prequalification of Medicines
Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections vanzyla@who.int 1 WHO GMP In this presentation: Background and Introduction
More informationIndustry Implications of Pharmaceutical Quality ICH Guidelines
EIPG General Assembly Industry Implications of Pharmaceutical Quality ICH Guidelines 20 th April 2008 Pharmaceutical Quality Develop a harmonised pharmaceutical quality system applicable across the lifecycle
More informationB i o s o l u t i o n s
B i o s o l u t i o n s Implementation of pharmatracker TM : A case study Prepared by Ocimum Biosolutions Ocimumbio Solutions August 2006 All rights reserved. 2 B i o s o l u t i o n s an ISO 9001:2000
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control
More informationAnnex 7 Guidelines on pre-approval inspections
World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the
More informationA Complete Drug Stability Program. Stability Lab Information Manager SL IM
A Complete Drug Stability Program Stability Lab Information Manager SL IM SLIM is a Fully Validated, World-Class Stability LIMS. SLIM combines the ease of use of browser style user interface and industry
More informationConsiderations for validating SDS Software v2.x Enterprise Edition for the 7900HT Fast Real-Time PCR System per the GAMP 5 guide
WHITE PAPER SDS Software v2.x Enterprise Edition Considerations for validating SDS Software v2.x Enterprise Edition for the 7900HT Fast Real-Time PCR System per the GAMP 5 guide This white paper describes
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry January 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationGuideline on Process Validation
1 2 3 4 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 Draft Draft Agreed by CHMP /
More informationProcess Redesign to Exploit the Tangible Benefits of Electronic
CHAPTER 6 Process Redesign to Exploit the Tangible Benefits of Electronic Signatures with acds Although not an apparent part of computer validation, process mapping and analysis is a vital first step in
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationElectronic Unreviewed Safety Question (eusq) System Lessons Learned
SANDIA NATIONAL LABORATORIES Electronic Unreviewed Safety Question (eusq) System Stephen A Coffing, Sandia National Laboratories; sacoffi@sandia.gov Jeffrey W Marr, HukariAscendent Inc.; jwmarr@sandia.gov
More informationLean Process Improvements for the GMP Laboratory
Lean Process Improvements for the GMP Laboratory ITRODUCTIO Pharmaceutical manufacturing costs the industry approximately $90 billion each year and represents twice the expenditure of research and development.
More informationState of Control Over the Lifecycle and Process Validation (New and Legacy Products)
State of Control Over the Lifecycle and Process Validation (New and Legacy Products) Grace McNally Branch Chief (acting), Regulatory Policy and Collaboration Branch FDA/CDER/Office of Compliance ICH Q10,
More informationPharmaceutical Quality Management System: Current Concept
Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute
More informationA Pragmatic Approach to the Testing of Excel Spreadsheets
A Pragmatic Approach to the Many GxP critical spreadsheets need to undergo validation and testing to ensure that the data they generate is accurate and secure. This paper describes a pragmatic approach
More informationSINGLE ERP SOFTWARE VS. MULTIPLE SOFTWARE SYSTEMS. Advantages of Using One Enterprise Solution for Your Process Manufacturing Business
Advantages of Using One Enterprise Solution for Your Process Manufacturing Business Advantages of Using One Enterprise Solution for Your Process Manufacturing Business INTRODUCTION Enterprise Resource
More informationFDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)
www.qadata.co.za Introduction FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) INITIAL REGULATION RELEASED High profile audit findings Industry complaints to wasting
More informationA Laboratory Information. Management System for the Molecular Biology Lab
A Laboratory Information L I M S Management System for the Molecular Biology Lab This Document Overview Why LIMS? LIMS overview Why LIMS? Current uses LIMS software Design differences LIMS software LIMS
More informationManual 074 Electronic Records and Electronic Signatures 1. Purpose
1. Purpose The purpose of this document is to provide an interpretation of FDA 21 CFR Part 11, Electronic Records; Electronic Signatures (ER/ES) and to provide guidance for acceptable practices in the
More informationWhite paper: How to implement a Quality Management System
White paper: How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485
More informationRx-360 Supplier Assessment Questionnaire (SAQ)
Rx-360 Supplier Assessment Questionnaire (SAQ) The Rx-360 Supplier Assessment Questionnaire (SAQ) was created by the Rx-360 Supplier-Led Working Group. The Supplier-Led Working Group is an Rx-360 working
More informationMeriCal Quality Profile
January 5, 2015 Dear Valued Customer, Since the implementation of new federal regulations, MeriCal Inc. has received a large volume of questionnaires and surveys regarding our services and procedures.
More informationIncreasing Lab Efficiency by Automating Sample Test Workflows Using OpenLAB Enterprise Content Manager (ECM) and Business Process Manager (BPM)
Increasing Lab Efficiency by Automating Sample Test Workflows Using OpenLAB Enterprise Content Manager (ECM) and Business Process Manager (BPM) Technical te Solution Benefits Streamlines sample-test workflows
More informationLaboratory Data Management Systems
Laboratory Data Management Systems Colin Taft, J&L LES project lead Eddie Ryan, Director, Systematic I.S. Strategies October 17 th, Dublin 1 Introductions Eddie Ryan, Systematic I.S. Strategies Ltd BE,
More informationImplementing New USP Chapters for Analytical Method Validation
Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: Ludwig_Huber@labcompliance.com Today s Agenda Handling Method Changes vs. Adjustments
More informationConsiderations for Management of Laboratory Data
Considerations for Management of Laboratory Data 2003 Scientific Computing & Instrumentation LIMS Guide, November 2003 Michael H Elliott Drowning in a sea of data? Nervous about 21 CFR Part 11? Worried
More informationHow to implement a Quality Management System
How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your
More informationHow To Control A Record System
Thermo Scientific Qtegra Intelligent Scientific Data Solution (ISDS) Software for 21 CFR Part 11 Compliant Laboratories Technical Note 43106 Key Words Compliance, Electronic Records, 21 CFR Part 11 Goal
More information21 CFR Part 11 White Paper
21 CFR Part 11 White Paper Version V8.00 SR1 ProLeiT AG Einsteinstrasse 8, D-91074 Herzogenaurach, Germany Phone: +49 (0) 9132 777-0 Fax: +49 (0) 9132 777-150 E-Mail: info@proleit.com Internet: http://www.proleit.com
More informationProduct Lifecycle Management in the Food and Beverage Industry. An Oracle White Paper Updated February 2008
Product Lifecycle Management in the Food and Beverage Industry An Oracle White Paper Updated February 2008 Product Lifecycle Management in the Food and Beverage Industry EXECUTIVE OVERVIEW Companies in
More informationGMP Training Course Quality Control. 20-21 October 2009. Lesley Graham Senior Inspector (UK)
GMP Training Course Quality Control 20-21 October 2009 Lesley Graham Senior Inspector (UK) Quality Control GMP in the QC Laboratory Certificates of Analysis Dealing with out of specification results Parametric
More informationEffective Asset Management for Life Sciences
Effective Asset Management for Life Sciences The business value Life sciences companies face stiff challenges to their long-term profitability in the form of mounting regulatory pressures, increasing price
More informationDevelopment and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO
Development and Validation of In Vitro Diagnostic Tests YC Lee, Ph.D. CEO 1 Validation of In Vitro Diagnostic Tests Validated d Diagnostic Test should: Provides test results that identify if positive i
More informationProcess Validation: Practical Aspects of the New FDA Guidance
Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory
More informationGuidance for Industry
Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationAuditing Chromatographic Electronic Data. Jennifer Bravo, M.S. QA Manager Agilux Laboratories
Auditing Chromatographic Electronic Data Jennifer Bravo, M.S. QA Manager Agilux Laboratories Outline Raw data paper or electronic record? Controls for electronic data Auditing electronic records Warning
More informationFocused on your goals SERVICES AND SUPPORT CAPABILITIES OVERVIEW
Focused on your goals SERVICES AND SUPPORT CAPABILITIES OVERVIEW Laboratories today face complex scientific and business challenges that require the support of a true service partner a service partner
More informationRegulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials
Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials Ron Hinkel, Director Quality Systems BioReliance Inc. Patti Rossman, President Globiox Purpose Keep pace
More informationQuality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle
Quality Risk Management 11 November 2011 Galway, Ireland Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Overview Regulatory
More informationWorkshop B Control Strategy
ICH-GCG ASEAN Workshop B Control Strategy Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference on Harmonisation
More informationSoftware Verification and Validation
Software Verification and Validation Georgia L. Harris Carol Hockert NIST Office of Weights and Measures 1 Learning Objectives After this session, using resources and references provided, you will be able
More informationGMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)
GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European
More informationLabChip GX/GXII with LabChip GxP Software
Regulatory Compliance LabChip GX/GXII with LabChip GxP Software Supporting Regulatory Compliance Caliper LabChip GX/GXII suite of instruments provides automated electrophoresis to analyze quality, size,
More informationData Governance Planning PDA 12 May 2015
Data Governance Planning PDA 12 May 2015 1 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2 Overview of Data Integrity 3 Data Information derived
More informationCompliance Response SIMATIC SIMATIC PCS 7 V8.1. Electronic Records / Electronic Signatures (ERES) Edition 03/2015. Answers for industry.
SIMATIC SIMATIC PCS 7 V8.1 Electronic Records / Electronic Signatures (ERES) Compliance Response Edition 03/2015 Answers for industry. Compliance Response Electronic Records / Electronic Signatures (ERES)
More informationA ChemoMetec A/S White Paper September 2013
NucleoCounter NC-3000, NucleoView NC-3000 Software and Code of Federal Regulation 21 Part 11; Electronic Records, Electronic Signatures (21 CFR Part 11) A ChemoMetec A/S White Paper September 2013 ChemoMetec
More informationNew changes to cleanroom & clean air device classifications: ISO 14644 1 & 2
New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 This white paper describes the changes outlined in the Draft International Standard (DIS) editions of ISO 14644-1 and ISO 14644-2.
More informationQuality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011
Quality by Design Approaches to Analytical Methods -- FDA Perspective Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 1 Outline What is Quality by Design (QbD) Role of Analytical
More information